ライフサイエンスコーパス: skin transplant

1 d graft survival in recipients of allogeneic skin transplant.

2 transfusion and anti-CD154 and given an allo-skin transplant.

3 istinct from male-specific minor Ags, and 3) skin transplant.

4 ssays), as well as in live mice and on human skin transplants.

5 H3a+H3b were used for orthotopic corneal and skin transplants.

6 ly mount a Th1 or Th2 response to allogeneic skin transplants.

7 In skin transplants, allograft survival was enhanced with A

8 uman B cells as well as in murine allogeneic skin transplant and alloantigen-induced T cell expansion

9 rats were challenged with Wistar-Furth (WF) skin transplants, followed 7 days later by transplantati

10 Skin transplanted from transgenic B6.A2 to B6 mice was r

11 C57BL/6J mice received skin transplants from BALB/c donors with: a) no treatmen

12 cipient chimeric dogs (n=4) were tolerant to skin transplants from their marrow donors but rejected s

13 Splenocytes from mice treated with CsA after skin transplants had no response to third-party alloanti

14 corneal-grafted mice, only CD8+ T cells from skin-transplanted mice mounted a cytotoxic response.

15 NK cells in Rag(-/-) mice using a stringent skin transplant model and found that NK cells at a resti

16 come these constraints we developed a murine skin transplant model in humanized mice and used it to t

17 In a skin transplant model in which rejection was mediated by

18 We now demonstrate using a skin transplant model that alloantibody indirectly induc

19 Using a highly immunogenic murine skin transplant model that resists transplantation toler

20 In the present study, we showed in a skin transplant model that the skin allografts contain a

21 studied class I determinant recognition in a skin transplant model with beta-galactosidase (beta-gal)

22 In a skin transplant model, blocking both CD28/CD40L and the

23 the rat and dog and is efficacious in a rat skin transplant model, indicating that S1P3 receptor ago

24 In a skin transplant model, the addition of IL-2 synergizes w

25 on of allografts using an immunogenic murine skin transplant model.

26 ctivation using a BALB/c to C57BL/6 heart or skin transplant model.

27 D8 T cells, we used a fully mismatched mouse skin transplant model.

28 of allograft response biomarkers in a mouse skin transplant model.

29 histocompatibility complex (MHC)-mismatched skin transplant model.

30 f intercellular adhesion molecule-1 in human skin transplanted on severe compromised immunodeficient

31 ammatory changes in human psoriatic lesional skin transplanted onto immunodeficient mice.

32 Human skin transplanted onto NSG mice develops an inflammatory

33 ophils in a transmigration model using human skin transplanted onto SCID mice.

34 human angiogenesis was established in human skin transplanted onto severe combined immunodeficient (

35 luate the immunologic response to allogeneic skin transplanted onto this region of lymphatic isolatio

36 bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by f

37 ferred CD27low NK cells into Rag1-/-T-bet-/- skin transplant recipients and found that the CD27low NK

38 response was generated against H4 peptide in skin transplant recipients.

39 nhanced the rapidity of cardiac allograft or skin transplant rejection in mice.

40 27high NK cells in a model of Tcell-mediated skin transplant rejection under costimulatory blockade c

41 onor haptoglobin enhanced the onset of acute skin transplant rejection, whereas haptoglobin-deficient

42 he influence of host and donor microbiota on skin transplant rejection.

43 ty complex class II alloantigens to suppress skin transplant rejection.

44 Syngeneic skin transplants served as controls.

45 ceiving Tregs display stable long-term human skin transplant survival along with a reduction in the C

46 Nonvascularized skin transplants triggered vigorous direct and indirect

47 First, psoriatic skin transplants were injected with either 1alpha,25-dih

48 smatched vascularized cardiac transplants or skin transplants were performed using BALB/c (H-2d), C57

49 neic primarily vascularized and conventional skin transplants were rejected at the same pace.

50 effected consistent rejection of HA-bearing skin transplants, whereas a significantly greater number